Supporting the Forefront of Cardiovascular Science
This prize provides
national and international recognition and support to those at the forefront of
The recipient of the Jay
and Jeanie Schottenstein Prize will be a leader in cardiovascular sciences, a
physician or biomedical scientist who has made extraordinary and sustained
leadership contributions to improving healthcare.
The Schottenstein Laureate
will also receive an honorarium of $100,000 (US).
Established by a $2
million endowment from humanitarian philanthropists Jay and Jeanie
Schottenstein, the prize is chartered to The Ohio State University Wexner
Medical Center’s Heart and Vascular Center, and will be awarded biennially.
2013 Winner of the Schottenstein Prize
FitzGerald is the recipient of the 2013 Schottenstein Prize. He is the McNeil Professor in Translational Medicine and Therapeutics
at the University of Pennsylvania in Philadelphia, where he chairs the
Department of Pharmacology and directs the Institute for Translational Medicine
and Therapeutics. Dr. FitzGerald’s research has been characterized by an
integrative approach to elucidating the mechanisms of drug action, drawing on
work in cells, model organisms and humans. His work contributed substantially
to the development of low-dose aspirin for cardioprotection. FitzGerald’s group
was the first to predict and then mechanistically explain the cardiovascular
hazard from NSAIDs. He has also discovered many products of lipid peroxidation
and established their utility as indices of oxidant stress in vivo. His
laboratory was the first to discover a molecular clock in the cardiovascular
system and has studied the importance of peripheral clocks in the regulation of
cardiovascular and metabolic function. Dr. FitzGerald has received the Boyle,
Coakley and Harvey medals, the Lucian, Scheele and Hunter Awards and the
Cameron, Taylor, Schottenstein and Jacob Herz Prizes and the Grand Prix of the
Lefoulon-Delalande Foundation. He is a member of the Institute of Medicine and
a Fellow of the Royal Society.
This prestigious prize provides national and international recognition to a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving healthcare; or who has successfully pursued innovative biomedical research with demonstrated translational benefits to patient care. Those honored will be practitioners and/or scientists whose accomplishments and contributions have taken place over a career of dedicated and focused scientific discovery. The prize is awarded biennially. The current application period has ended for 2013. Check back in the future for application information for the 2015 award.
Learn More About Jay and Jeanie Schottenstein
Jay and Jeanie Schottenstein are passionate about Ohio State. Their children – Joseph, Jeffrey and Jonathan – have each attended, or are attending the University. Jeanie, herself, is a graduate.
The passion doesn’t stop there. Jay and Jeanie and Jay’s parents and siblings all have philanthropic ties to the University; the Jerome Schottenstein Center bears his late father's name. One might say the colors of scarlet and gray run deep in Jay’s and Jeanie’s veins.
It was natural then, for them to pledge $2 million to The Ohio State University Wexner Medical Center in 2008 to create the Jay and Jeanie Schottenstein Prize in Cardiovascular Science. The prize establishes an endowed fund to award up to $100,000 biennially to a physician or researcher who is an international leader in the field of cardiovascular sciences.
Because prizes of such magnitude are rare in scientific research and medicine, the Schottenstein Prize is expected to generate a lot of excitement.
"By providing this prize for cardiovascular sciences, we hope to further establish Ohio State as a leader in cardiovascular care and assure that it continues to set the bar for other institutions, nationally and internationally,” Jay says.
“This award will create a connection between Ohio State and some of the most outstanding cardiovascular scientists in the world,” adds Jeanie. “Our goal in establishing this prize is to make a strong institution even stronger.”
According to Ohio State’s Heart and Vascular Center Director, Thomas Ryan, MD, this prize will not only provide international recognition to someone who is on the leading edge of his or her field, it will also offer an unparalleled educational opportunity for OSU’s academic, medical and research communities and the community at large. The awarding of this prize will expose these groups to the knowledge and discoveries of a physician or researcher of great talent and caliber.
“Our vision at Ohio State’s Heart and Vascular Center is to leverage advanced techniques and technologies to innovate and translate knowledge into personalized heart care,” explains Ryan. “The Schottenstein Prize offers another avenue through which to accomplish this.”
“The creation of the Shottenstein Prize addresses two important goals. First, it greatly enhances the reputation of OSU on the international stage as an institution where world-class science is recognized and valued. Second, it will expose our students, trainees, and faculty to the luminaries in modern cardiovascular medicine. I am both grateful and proud that we have been afforded this wonderful opportunity.”
In addition to their philanthropic endeavors, the Schottensteins are very involved in the central Ohio business community. An Ohio-based investor and business leader of national renown, Jay is chairman of several corporations, including Schottenstein Stores and American Eagle Outfitters. Both serve as directors or trustees of several non-profit organizations throughout the region.